Research Paper Volume 12, Issue 16 pp 16155—16171
RPP30, a transcriptional regulator, is a potential pathogenic factor in glioblastoma
Figure 4. The correlation between RPP30 and clinicopathological characteristics in primary GBM. (A, C) RPP30 was enriched in TP53 mutation and IDH1 mutation GBM samples in CGGA and TCGA databases. The expression of RPP30 was independent of the amplification state of EGFR. The unpaired t-test was used in differential analysis. ns: no significant difference. *: p<0.05. **: p<0.01. (B, D) Expression pattern of RPP30 in four transcriptome subtypes of GBM. One Way ANOVA was used in differential analysis.